Short term effect of intravenous treprostinil in term and preterm infants with pulmonary hypertension

BMC Pediatrics

Table 3 Clinical courses before discharge

	Term (n = 11)	Preterm (n = 18)	p value
Treprostinil use more than 4 weeks	3 (27.3)	4 (22.2)	1.000
Death before discharge^a	2 (18.2)	11 (61.1)	0.052
Weaning from treprostinil before death or discharge	11 (100)	9 (50)	0.005
Requiring other PH medication after treprostinil than iNO^b	6 (54.6)	7 (77.8)	0.374
Duration of other PH medication (days)^b	73.5 [68–94]	169 [40–938]	0.412

Values are expressed as n (%) or median [interquartile range]. PH, pulmonary hypertension; iNO, inhaled nitric oxide
^aIncluding death during 4 weeks of study period
^bAmong infants who could be weaned from treprostinil before death

ISSN: 1471-2431